Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia

Drug Testing and Analysis

Volumn 6, Issue 7-8, 2014, Pages 840-845

  Burns, Lucy ^a   Roxburgh, Amanda ^a   Bruno, Raimondo ^b   Van Buskirk, Joe ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Ecstasy; Internet; New psychoactive substances

Indexed keywords

PATIENT MONITORING;

AUSTRALIA; DRUG MARKETS; DRUG MONITORING SYSTEM; ECSTASY; ILLICIT DRUG; MEASUREMENTS OF; NEW PSYCHOACTIVE SUBSTANCE; REPORTING SYSTEMS; RESEARCH CENTER; SYSTEMS MONITOR;

DRUG PRODUCTS;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; RECREATIONAL DRUG; CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT; STREET DRUG;

ARTICLE; AUSTRALIA; DRUG ABUSE PATTERN; DRUG MARKETING; DRUG MONITORING; INTERNET; PRIORITY JOURNAL; DRUG CONTROL; DRUG TRAFFIC; HUMAN; PROCEDURES; SUBSTANCE-RELATED DISORDERS; SUPPLY AND DISTRIBUTION;

AUSTRALIA; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG AND NARCOTIC CONTROL; DRUG TRAFFICKING; HUMANS; INTERNET; PSYCHOTROPIC DRUGS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84904554484     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1613     Document Type: Article

References (42)

1. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey. AIHW, Canberra, 2011.
2. V. White, E. Bariola . Australian secondary school students' use of tobacco, alcohol, and over-the-counter and illicit substances in 2011. The Cancer Council Victoria, Melbourne, 2012.
3. N. Sindicich, L. Burns . Australian Trends in Ecstasy and related Drug Markets 2011. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2012.
4. J. Sweeney, S. Macgregor . Decrease in use of ecstasy/MDMA. Australian Institute of Ciminology, Canberra, 2012.
5. A. Roxburgh, L. Burns . Drug-related hosptial stays in Australia, 1993-2011. National Drug and Alcohol Research Centre, Sydney, 2013.
6. C. Chen, C. Kostakis, R.J. Irvine, J.M. White . Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3, 4-methylenedioxy-N-methylamphetamine (MDMA). Forensic Sci. Int. 2013, 231, 278.
7. J. Van Buskirk, A. Roxburgh, R. Bruno, L. Burns . Drugs and the Internet. National Drug and Alcohol Research Centre, Sydney, 2013.
8. Ministerial Council on Drug Strategy. National Drug Strategy 2010-2015. Commonwealth of Australia, Canberra, 2011.
9. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2013. United Nations, New York, 2013.
10. S. Begg, T. Vos, B. Barker, C. Stevenson, L. Stanley, A. Lopez . The burden of disease and injury in Australia 2003. AIHW, Canberra, 2007.
11. F. Shand, P. Gates, J. Fawcett, R. Mattick . The treatment of alcohol problems: A review of the evidence. Australian Government Department of Health and Ageing, Canberra, 2003.
12. G. Wardlaw . Final Report: Illicit Drug Reporting System. Consultant's report to the Commonwealth Department of Human Services and Health. National Drug and Alcohol Research Centre, Sydney, 2008.
13. G.J. Dore, M. Law, M. MacDonald, J.M. Kaldor . Epidemiology of hepatitis C virus infection in Australia. J. Clin. Virol. 2003, 26, 171.
14. A. Roxburgh, L. Burns . Accidental drug-induced deaths due to opioids in Australia, 2009. National Drug and Alcohol Research Centre, Sydney, 2013.
15. L. Topp, R. McKetin . Supporting evidence-based policy-making: A case study of the Illicit Drug Reporting System in Australia. B. Narcotics 2003, LV, 23.
16. N. Sindicich, L. Burns . Australian Trends in Ecstasy and related Drug Markets 2012. Findings from the Ecstasy and Related Drugs Reporting System. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2013.
17. E.W. Boyer, M. Shannon, P.L. Hibberd . The Internet and psychoactive substance use among innovative drug users. Pediatrics 2005, 115, 302.
18. P.M. Wax . Just a click away: Recreational drug Web sites on the Internet. Pediatrics 2002, 109, 96.
19. P. Deluca, Z. Davey, O. Corazza, L. Di Furia, M. Farre, L.H. Flesland, M. Mannonen, A. Majava, T. Peltoniemi, M. Pasinetti, C. Pezzolesi, N. Scherbaum, H. Siemann, A. Skutle, M. Torrens, P. van der Kreeft, E. Iversen, F. Schifano . Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog. Neuro-Psychoph. 2012, 39, 221.
20. Z. Davey, O. Corazza, F. Schifano, P. Deluca, P.W.M. Group . Mass-information: Mephedrone, myths, and the new generation of legal highs. Drug Alcohol Today 2010, 10, 24.
21. U. Solberg, R. Sedefov, P. Griffiths, in Developing a sound methodology to monitor the online availability of new drugs/'legal highs (Eds: J. Fountain, V. Asmussen Frank, D.J. Korf ). Pabst Science Publishers, Germany, 2011.
22. J.C. Drees, J.A. Stone, A.H.B. Wu . Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J. Forens. Sci. 2009, 54, 1485.
23. B. Sanders, S.E. Lankenau, J.J. Bloom, D. Hathazi . " Research chemicals" Tryptamine and phenethylamine use among high-risk youth. Subst. Use Misuse 2008, 43, 389.
24. S. Banerji, C.M. Deutsch, A.C. Bronstein . Spice ain't so nice. Clin. Toxicol. 2010, 48, 632.
25. N. Sindicich, L. Burns . Australian Trends in Ecstasy and related Drug Markets 2010: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2011.
26. N. Sindicich, L. Burns . Australian Trends in Ecstasy and related Drug Markets 2009: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2010.
27. N. Christin . Traveling the Silk Road: A measurement analysis of a large anonymous online marketplace, in World Wide Web Conference. World Wide Web conference Committee, Rio de Janeiro, Brazil, 2013.
28. M.J. Barratt . Silk Road: Ebay for drugs. Addiction 2012, 107, 683.
29. Bitcoin. Bitcoin P2P digital currency. Available at: http://bitcoin.org/ [14 March 2013].
30. H.A. Spiller, M.L. Ryan, R.G. Weston, J. Jansen . Clinical experience with and analytical confirmation of 'bath salts' and 'legal highs' (synthetic cathinones) in the United States. Clin. Toxicol. 2011, 49, 499.
31. T. McGuinness . Bath salts: They are not what you think. J. Psychosoc. Nurs. 2012, 50, 17.
32. R. Bruno, R. Poesiat, A.J. Matthews . Internet monitoring for EPS. Drug Alcohol Rev. 2013, 32, 541.
33. S. Yin, M. Ho . Monitoring a toxicological outbreak using Internet search query data. Clin. Toxicol. 2012, 50, 818.
34. A. McNeilage . Synthetic drug ban won't halt online link. The Sydney Morning Herald, 3 August 2013 Available at: http://www.smh.com.au/nsw/synthetic-drug-ban-wont-halt-online-link-20130608-2nwv1.html [3 August 2013].
35. Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2013, 10 June, UK Parliament, UK, 2013.
36. A. Travis . Two new 'legal highs' to be banned for 12 months. Available at: http://www.theguardian.com/society/2013/jun/04/legal-highs-benzo-fury-nbome-banned [3 August 2013].
37. T.C. Ayres, J.W. Bond . A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill) health. Legal highs or illegal highs? Brit. Med. J. Open. 2012, 2, e000977.
38. S.D. Brandt, S. Freeman, H.R. Sumnall, F. Measham, J. Cole . Analysis of NRG Legal highs in the UK: Identification and formation of novel cathinones. Drug Test. Anal. 2010, 3, 569.
39. S.D. Brandt, H.R. Sumnall, F. Measham, J. Cole . Analyses of second-generation 'legal highs' in the UK: Initial findings. Drug Test. Anal. 2010, 2, 377.
40. S.D. Brandt, H.R. Sumnall, F. Measham, J. Cole . Second generation mephedrone. The confusing case of NRG-1. Brit. Med. J. 2010, 341, c3564.
41. A.L. Jones . Legal 'highs' available through the internet-implications and solutions? Quarterly J. Med. 2010, 103, 535.
42. O. Corazza, Z. Demetrovics, W. Van Den Brink, F. Schifano . 'Legal highs' an inappropriate term for 'novel psychoactive drugs' in drug prevention and scientific debate. Int. J. Drug Policy 2013, 24, 82.